SMTL ID : 7t78.1 (1 other biounit)

CRYSTAL STRUCTURE OF GLUCOKINASE (HEXOKINASE 4) COMPLEXED WITH LIGAND DIETHYL ({2-[3-(4-METHANESULFONYLPHENO XY)-5-{[(2S)-1-METHOXYPROPAN-2-YL]OXY}BENZAMIDO]-1,3-THIAZ OL-4-YL}METHYL)PHOSPHONATE

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x GLC: alpha-D-glucopyranose(Non-covalent)

GLC.1: 14 residues within 4Å: Chain A: S.152, F.153, P.154, T.169, K.170, N.205, D.206, I.226, G.230, C.231, N.232, E.257, Q.288, E.291 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:T.169, A:K.170, A:N.205, A:N.205, A:C.231, A:N.232, A:E.257, A:E.257, A:Q.288 Water bridges: A:K.170, A:G.230 Salt bridges: A:K.170

1 x NA: SODIUM ION(Non-functional Binders)

NA.2: 4 residues within 4Å: Chain A: M.239, V.242, V.245, G.247 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:V.245

1 x G2T: diethyl {[2-(3-[4-(methanesulfonyl)phenoxy]-5-{[(2S)-1-methoxypropan-2-yl]oxy}benzamido)-1,3-thiazol-4-yl]methyl}phosphonate(Non-covalent)

G2T.3: 18 residues within 4Å: Chain A: Y.62, V.63, R.64, S.65, T.66, E.68, G.69, S.70, W.100, I.160, M.211, I.212, Y.215, Y.216, V.453, V.456, A.457, K.460 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:T.66, A:I.212, A:Y.215, A:Y.215, A:Y.216, A:V.456, A:K.460 Hydrogen bonds: A:R.64, A:R.64, A:T.66

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 3 residues within 4Å: Chain A: Q.19, I.20, E.23 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shi, Y. et al., Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1 H -pyrazol-1-yl)methyl)phosphonate (BMS-820132). J.Med.Chem. (2022)

Release Date

2022-03-02

Peptides

Isoform 2 of Hexokinase-4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Isoform 2 of Hexokinase-4

Related Entries With Identical Sequence